“Patient perception is an important aspect of developing an effective treatment plan, and we should be able to arm patients with accurate data to help them make an informed decision,” write Whitney Renee Smith, MD, and Gopal H. Badlani, MD.
“Patients are having a hard time getting diagnosed because physicians are leaving medical training and medical education without getting this solid curriculum around female sexual…
James C. Ulchaker, MD, shares his insights on the current range of BPH therapies.
Already Registered? Login here. REGISTER NOW Already registered?
Jared S. Winoker, MD, addresses the wide range of stone burdens treated by the CVAC system for the study.
Keep up with live updates of the FDA Advisory Committee meeting on talazoparib plus enzalutamide for mCRPC.
Ashish Kamat, MD, MBBS; Sam Chang, MD, MBA; Bogdana Schmidt, MD, MPH; and Katie Murray, DO, MS, discuss how management of non–muscle-invasive bladder cancer (NMIBC)…
Karyn S. Eilber, MD, discusses treatment of genitourinary syndrome of menopause.
Keep up with live updates from the Oncologic Drugs Advisory Committee meeting here.
Panelists discuss how non–muscle-invasive bladder cancer (NMIBC) is staged, graded, and treated according to risk stratification, with detailed explanations of low-, intermediate-, and high-risk categories…
Results from the phase 3 AMPLIFY trial are intended to support an application to the FDA for potential approval of 64Cu-SAR-bisPSMA.
